Liver kinase B1 (LKB1) staves off γδ T-cell-mediated autoimmune liver disease

被引:0
|
作者
Wang, Yiwen [1 ]
Wu, Lan [1 ]
Van Kaer, Luc [1 ]
机构
[1] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA
关键词
D O I
10.1038/s41423-024-01172-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:641 / 642
页数:2
相关论文
共 50 条
  • [21] Integrin-binding Protein Nischarin Interacts with Tumor Suppressor Liver Kinase B1 (LKB1) to Regulate Cell Migration of Breast Epithelial Cells
    Jain, Prachi
    Baranwal, Somesh
    Dong, Shengli
    Struckhoff, Amanda P.
    Worthylake, Rebecca A.
    Alahari, Suresh K.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (22) : 15495 - 15509
  • [22] Josephin domain containing 2 (JOSD2) promotes lung cancer by inhibiting LKB1 (Liver kinase B1) activity
    Yuan, Tao
    Zeng, Chenming
    Liu, Jiawei
    Zhao, Chenxi
    Ge, Fujing
    Li, Yuekang
    Qian, Meijia
    Du, Jiamin
    Wang, Weihua
    Li, Yonghao
    Liu, Yue
    Dai, Xiaoyang
    Zhou, Jianya
    Chen, Xueqin
    Ma, Shenglin
    Zhu, Hong
    He, Qiaojun
    Yang, Bo
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [23] Autophagy Inhibition Sensitizes Liver Kinase B1 (LKB1)-Deficient Kras-Driven Lung Tumors to MEK Inhibitor Trametinib
    Bhatt, Vrushank
    Lan, Taijin
    Lopes, Eduardo Cararo
    Wang, Wenping
    Khayati, Khoosheh
    Wang, Jianming
    Kong, Jerry
    Raju, Akash
    Luo, Xuefei
    Hu, Zhixian
    Hu, Wenwei
    Su, Xiaoyang
    White, Eileen
    FASEB JOURNAL, 2021, 35
  • [24] Josephin domain containing 2 (JOSD2) promotes lung cancer by inhibiting LKB1 (Liver kinase B1) activity
    Tao Yuan
    Chenming Zeng
    Jiawei Liu
    Chenxi Zhao
    Fujing Ge
    Yuekang Li
    Meijia Qian
    Jiamin Du
    Weihua Wang
    Yonghao Li
    Yue Liu
    Xiaoyang Dai
    Jianya Zhou
    Xueqin Chen
    Shenglin Ma
    Hong Zhu
    Qiaojun He
    Bo Yang
    Signal Transduction and Targeted Therapy, 9
  • [25] Autophagy Inhibition Sensitizes Liver Kinase B1 (LKB1)-Deficient Kras-Driven Lung Tumors to MEK Inhibitor Trametinib
    Bhatt, Vrushank
    Khayati, Khoosheh
    Kong, Jerry
    Raju, Akash
    Su, Xiaoyang
    Guo, Jessie
    FASEB JOURNAL, 2020, 34
  • [26] Autophagy inhibition sensitizes Liver Kinase B1 (LKB1) - deficient Kras-driven lung tumors to MEK inhibitor Trametinib
    Bhatt, Vrushank Dharmesh
    Khayati, Khoosheh
    Kong, Jerry
    Raju, Akash
    Hu, Zhixian
    Su, Xiaoyang
    Guo, Jessie Yanxiang
    CANCER RESEARCH, 2020, 80 (16)
  • [27] Liver kinase B1 (LKB1) and phosphorylated AMP kinase (AMPK) expression in small cell lung cancer (SCLC): Association with prognosis and tumour immune microenvironment (TIME) features
    Bonanno, L.
    Dal Maso, A.
    Pavan, A.
    Zulato, E.
    Esposito, G.
    Fassan, M.
    Nardo, G.
    Pasello, G.
    Guarneri, V.
    Calabrese, F.
    Rea, F.
    Indraccolo, S.
    Conte, P. F.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S723 - S724
  • [28] The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin
    Shaw, RJ
    Lamia, KA
    Vasquez, D
    Koo, SH
    Bardeesy, N
    DePinho, RA
    Montminy, M
    Cantley, LC
    SCIENCE, 2005, 310 (5754) : 1642 - 1646
  • [29] The natural product antroalbol H promotes phosphorylation of liver kinase B1 (LKB1) at threonine 189 and thereby enhances cellular glucose uptake
    Wang, Fang
    Yang, Xiaoyan
    Lu, Yanting
    Li, Zhenghui
    Xu, Yuhui
    Hu, Jing
    Liu, Jikai
    Xiong, Wenyong
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2019, 294 (27) : 10415 - 10427
  • [30] Liver kinase B1 expression (LKB1) is repressed by estrogen receptor alpha (ERα) in MCF-7 human breast cancer cells
    Linher-Melville, Katja
    Zantinge, Stephanie
    Singh, Gurmit
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 417 (03) : 1063 - 1068